Carolyn Ianieri, DO
Obstetrics & Gynecology · Doylestown, PANPI 1972501377
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $961 of the $1,261 with a category attached, or 76.2%. 16 manufacturers reported payments, led by Aspira Women's Health Inc at 27.0% of the total. Reporting peaked in 2020 at $406 and has fallen 81.3% since, to $76 in 2025.
Across 39 payments — averaging $32.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aspira Women's Health Inc$340
- AbbVie$234
- THD America, Inc.$124
- Coopersurgical, Inc.$96
- AstraZeneca$92
- Astellas Pharma US Inc$74
- plus $301 from 10 others
What the payments were for
- Consulting fees$30024%
- Food & beverage$96176%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aspira Women's Health Inc | 3 | $340 |
| AbbVie(2 entities) | 12 | $234 |
| THD America, Inc. | 1 | $124 |
| Coopersurgical, Inc. | 3 | $96 |
| AstraZeneca | 1 | $92 |
| Astellas Pharma US Inc | 3 | $74 |
| Mimedx Group, Inc. | 1 | $44 |
| Organon | 2 | $43 |
| Evofem Biosciences, Inc. | 2 | $39 |
| Therapeuticsmd, Inc. | 2 | $32 |
| Exeltis, USA Inc. | 2 | $32 |
| Myovant Sciences Inc. | 1 | $29 |
| Hologic Sales And Service, LLC | 2 | $29 |
| Avion Pharmaceuticals | 2 | $24 |
| Pfizer | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OVA1$300
How this compares
$1,261 in reported general payments places this provider in the 75th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alendronate Sodium | 14 | $66 |
| Misoprostol | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Doylestown
- Stephen KlaskoPhiladelphia$2.2M
- Stephanie SoberPhiladelphia$1.8M
- Barry JacobsonGlen Mills$302K
- Timothy GrubeFrackville$260K
- Russell StankiewiczLewisburg$202K
- Jamille Nagtalon-RamosPhiladelphia$183K
- Timothy DeimlingMechanicsburg$182K
- Gerald HarkinsMechanicsburg$140K
- Kirthik ParthasarathyWest Reading$103K
- Catherine ChappellPittsburgh$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.